Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-01-15 @ 5:28 AM
Study NCT ID:
NCT06199232
Status:
RECRUITING
Last Update Posted:
2024-12-04
First Post:
2023-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed from Standard Systemic Treatment
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-23
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-24
First Submit QC Date:
None
Study First Post Date:
2024-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-01
Last Update Post Date:
2024-12-04
Last Update Post Date Type:
ACTUAL